Bebtelovimab Solution for injection

BEBTELOVIMAB (beb te loe vi mab) treats COVID-19. It may decrease the risk of developing severe symptoms of COVID-19. It may also decrease the chance of going to the hospital. This medication is no longer approved for use by the FDA.

This medication is injected into a vein. It is given by your care team in a hospital or clinic setting.

Talk to your care team about the use of this medication in children. While it may be given to children as young as 12 years, precautions do apply.

Side effects that you should report to your care team as soon as possible:

• Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
• Infusion-related reactions—chills, fever, chest pain, trouble breathing, dizziness, fast or irregular heartbeat

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

• Nausea
• Pain, redness, or irritation at injection site
• Vomiting

This medication is given in a hospital or clinic. It will not be stored at home.

They need to know if you have any of these conditions:

• Any allergies
• Any serious illness
• Have received a COVID-19 vaccine
• An unusual or allergic reaction to bebtelovimab, other medications, foods, dyes, or preservatives
• Pregnant or trying to get pregnant
• Breast-feeding

• COVID-19 vaccines

This does not apply. This medication is not for regular use.

Your condition will be monitored carefully while you are receiving this medication. Visit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better or if they get worse.

After receiving this medication, you may need to wait before getting the COVID-19 vaccine. Talk to your care team about when you can receive the COVID-19 vaccine.